Roswell Park Cancer Center Institute — Buffalo, New York

Roswell Park Cancer Center Institute is a clinical research site located in Buffalo, New York, United States 14263.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Center Institute has participated in 2 clinical trials.

Therapeutic areas: Acute Myeloid Leukemia, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors.

Sponsors: Sumitomo Pharma America, Inc., Pfizer.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Center Institute?

Roswell Park Cancer Center Institute has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Center Institute conducted?

Roswell Park Cancer Center Institute has 2 clinical trials on record. Their work covers Acute Myeloid Leukemia, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors.

Is Roswell Park Cancer Center Institute accredited by Crixeo Health?

Roswell Park Cancer Center Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Center Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.